Optiver Holding
MGNX icon

Optiver Holding’s MacroGenics MGNX Stock Holding History

Optiver Holding’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01K Buy
+219
New +$828 ﹤0.01% 2480
2025
Q4 		– Sell
-2
Closed -$3 – 2777
2025
Q3 		$3 Buy
+2
New +$3 ﹤0.01% 2664

Other funds holding MGNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Optiver Holding's MGNX Position: Q2 2026 in Review

Optiver Holding opened a new position in MacroGenics (MGNX) in Q2 2026: 219 shares worth $1.01K. The stake represents ﹤0.01% of the portfolio and ranks #2480 among its holdings. This is a return to the name: Optiver Holding previously reported a position in MGNX as recently as Q3 2025.

Optiver Holding first reported a position in MGNX in Q3 2025 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

  • Optiver Holding held 219 shares of MacroGenics worth $1.01K as of Q2 2026.
  • MacroGenics was a new Optiver Holding position in Q2 2026.
  • MacroGenics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2480 holding.
  • Optiver Holding first reported a position in MacroGenics in Q3 2025 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.